Biopharmaceutical benchmarks 2018

被引：700

作者：

Walsh, Gary ^{[1
,2
]}

机构：

[1] Univ Limerick, Dept Chem Sci, Ind Biochem Program, Limerick, Ireland

[2] Univ Limerick, Bernal Inst, Limerick, Ireland

来源：

NATURE BIOTECHNOLOGY | 2018年 / 36卷 / 12期

关键词：

D O I：

10.1038/nbt.4305

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

[No abstract available]

引用

页码：1136 / 1145

页数：10

共 17 条

[1] CAR T-cell Therapy: A New Era in Cancer Immunotherapy
Androulla, Miliotou N.
Lefkothea, Papadopoulou C.
[J]. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2018, 19 (01) : 5 - 18
[2] [Anonymous], 2016, IMPACT BIOSIMILAR CO
[3] [Anonymous], 2017, BIOSIMILARS EU REPOR
[4] The transgenic animal platform for biopharmaceutical production
Bertolini, L. R.
Meade, H.
Lazzarotto, C. R.
Martins, L. T.
Tavares, K. C.
Bertolini, M.
Murray, J. D.
[J]. TRANSGENIC RESEARCH, 2016, 25 (03) : 329 - 343
[5] FirstWord, 2018, CHART GLOB BIOS PIP
[6] Gene therapy clinical trials worldwide to 2017: An update
Ginn, Samantha L.
Amaya, Anais K.
Alexander, Ian E.
Edelstein, Michael
Abedi, Mohammad R.
[J]. JOURNAL OF GENE MEDICINE, 2018, 20 (05)
[7] CAR T cell immunotherapy for human cancer
June, Carl H.
O'Connor, Roddy S.
Kawalekar, Omkar U.
Ghassemi, Saba
Milone, Michael C.
[J]. SCIENCE, 2018, 359 (6382) : 1361 - 1365
[8] Antibodies to watch in 2018
Kaplon, Helene
Reichert, Janice M.
[J]. MABS, 2018, 10 (02) : 183 - 203
[9] Harnessing T cells to fight cancer with BiTE® antibody constructs - past developments and future directions
Klinger, Matthias
Benjamin, Jonathan
Kischel, Roman
Stienen, Sabine
Zugmaier, Gerhard
[J]. IMMUNOLOGICAL REVIEWS, 2016, 270 (01) : 193 - 208
[10] CAR T Cells in Trials: Recent Achievements and Challenges that Remain in the Production of Modified T Cells for Clinical Applications
Koehl, Ulrike
Arsenieva, Stanislava
Holzinger, Astrid
Abken, Hinrich
[J]. HUMAN GENE THERAPY, 2018, 29 (05) : 559 - 568

← 1 2 →